Zomedica Corp. (ZOM)
| Market Cap | 488.20M |
| Revenue (ttm) | 29,817 |
| Net Income (ttm) | -17.90M |
| Shares Out | 973.66M |
| EPS (ttm) | -0.07 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22,093,249 |
| Open | 0.504 |
| Previous Close | 0.510 |
| Day's Range | 0.495 - 0.513 |
| 52-Week Range | 0.063 - 2.910 |
| Beta | 0.42 |
| Analysts | Buy |
| Price Target | 1.20 (+140.5%) |
| Est. Earnings Date | Nov 11, 2021 |
About ZOM
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA, a diagnostic biosensor platform for the detection of thyroid disorders in dogs and cats, and adrenal disorders in dogs. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences...
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for Zomedica stock is "Buy" and the 12-month stock price forecast is 1.20.
News
Zomedica Management Finally Delivers Some Good News
Zomedica's acquisition is precisely what was needed to get ZOM stock out of its lethargy. Long-term, it could be a game-changer.
Zomedica Stock Will Need More Than a Change in Management to Bounce Back
While a C-suite scenery change might be good for Zomedica, the shift may not provide a similar outcome for ZOM stock. The post Zomedica Stock Will Need More Than a Change in Management to Bounce Back ap...
New CEO and Acquisition Could Breathe New Life Into Zomedica
A turnaround in ZOM stock may happen sooner rather than later as Zomedica undergoes an executive-level change and builds out its business. The post New CEO and Acquisition Could Breathe New Life Into Zo...
Zomedica Has Potential, but It's Far Too Expensive for Now
ZOM stock can be a pet care industry leader, but it needs to make significant improvements before becoming a solid long-term play. The post Zomedica Has Potential, but It's Far Too Expensive for Now app...
The Challenges for Zomedica Continue, But It Still Has Huge Potential
Cautious investors may want to hold off, as no matter what direction it goes (higher or lower), it'll do so in a big way. But if you can stomach the risk, and have patience to wait out its current troub...
Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan
ANN ARBOR, Mich., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostic and therapeutic produ...
Here's Why Zomedica Stock Popped Today
Investors applauded the company's move to diversify its business.
Investing in Penny Stocks? Here's 3 That Retail Traders Are Watching
These penny stocks are pushing up right now, are they on your watchlist? The post Investing in Penny Stocks?
3 Hot Penny Stocks: Why ZOM, AEZS and PROG Are Seeing Big Gains Today
A few hot penny stocks are seeing major movement on Friday as shares ride higher and we've got all the details traders need. The post 3 Hot Penny Stocks: Why ZOM, AEZS and PROG Are Seeing Big Gains Toda...
ZOM Stock: There's a $71 Million Reason Zomedica Is Gaining Today
ZOM stock is up big today on news of a big merger. The company is acquiring proven vet tech outfit PulseVet in an all-cash deal.
Why Zomedica Shares Are Soaring Today
Zomedica Corp (AMEX:ZOM) is trading significantly higher Friday after the company announced the purchase of Pulse Veterinary Technologies for $70.9 million in cash and stock. Pulse Veterinary Technologi...
Zomedica Stock Soars After $71M Pulse Veterinary Acquisition
Zomedica Corp (NYSE:ZOM) has acquired the Pulse Veterinary Technologies businesses for $70.9 million in a cash and stock transaction. Pulse Veterinary Technologies (PulseVet) provides electro-hydraulic ...
Zomedica Acquires PulseVet
ANN ARBOR, Mich., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostic and therapeutic produ...
With the Crickets Chirping at Zomedica HQ, Why Buy the Stock?
The only word out of Zomedica in September was its announcement of a new director. That's not the news ZOM stock needs right now.
7 Stocks to Sell Now to Lock in Profits While You Still Can
It's the time of the year when it's just as important to identify which stocks to sell as it is to know which ones to buy. The post 7 Stocks to Sell Now to Lock in Profits While You Still Can appeared f...
Even 53 Cents Is Too Much for Zomedica Stock Right Now
At one point, investors loved Zomedica. But until its plans come to fruition, ZOM stock doesn't look like much of a deal.
4 Penny Stocks Retail Investors Can't Stop Buying
Penny stocks are usually more trouble than they're worth.
Sean Whelan Appointed to Board of Directors
ANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs a...
Best Reddit Penny Stocks to Buy? 3 to Know About Right Now
Why investors are focusing on these 3 Reddit penny stocks right now The post Best Reddit Penny Stocks to Buy? 3 to Know About Right Now appeared first on Penny Stocks to Buy, Picks, News and Information...
If at First Zomedica Doesn't Succeed, It Tries, Tries Again
The launch of the Truforma diagnostic platform didn't go perfectly for Zomedica, but holders of ZOM stock still have reason for optimism. The post If at First Zomedica Doesn't Succeed, It Tries, Tries A...
Is Zomedica Stock Worth the Risk? Unfortunately It's Complicated
Zomedica started selling its TRUFORMA vet diagnostic system in March, but ZOM stock won't see upside until supplier assay issues are resolved. The post Is Zomedica Stock Worth the Risk?
Why Economic Pressure May Build Against Zomedica
Although ZOM stock banks superficially on millennials' love for pets, brewing economic pressures may undo this catalyst. The post Why Economic Pressure May Build Against Zomedica appeared first on Inves...
5 Ultra-Popular Stocks to Avoid Like the Plague in September
Popularity doesn't necessarily translate to profitability on Wall Street.
Penny Stock Investors Are Watching These Hot Industries in September
Looking for the best industries to find penny stocks in 2021? Check these 3 out The post Penny Stock Investors Are Watching These Hot Industries in September appeared first on Penny Stocks to Buy, Picks...
Zomedica Continues to Execute Poorly
It's been 3.5 months since Zomedica launched Truforma. Unfortunately, due to its poor execution, ZOM stock continues to suffer.